Vasundhara Rasayans Ltd Valuation Shifts Amidst Market Volatility

Valuation Metrics and Recent Changes

As of 20 Mar 2026, Vasundhara Rasayans Ltd trades at ₹118.50, up 5.05% from the previous close of ₹112.80. Despite this intraday gain, the stock remains significantly below its 52-week high of ₹273.95, having touched a low of ₹101.15 during the same period. The company’s P/E ratio currently stands at 9.91, a figure that has contributed to the downgrade of its valuation grade from attractive to fair. This P/E is relatively modest compared to many of its peers, yet it signals a shift in market sentiment.

The price-to-book value ratio is 1.06, indicating the stock is trading close to its book value. This metric, combined with an enterprise value to EBITDA (EV/EBITDA) ratio of 12.23, suggests that while the stock is not excessively expensive, it no longer enjoys the valuation discount it once did. The EV to EBIT ratio is 14.25, and the EV to sales ratio is 1.15, both reflecting a valuation that is more balanced but less compelling than before.

Comparative Analysis with Industry Peers

When compared with other companies in the Pharmaceuticals & Biotechnology sector, Vasundhara Rasayans Ltd’s valuation appears more reasonable but less attractive. For instance, Titan Biotech is classified as very expensive with a P/E of 59.7 and an EV/EBITDA of 48.67, while Sanstar and Stallion India also trade at expensive multiples with P/Es of 76.78 and 28.23 respectively. On the other hand, companies like I G Petrochems and Gulshan Polyols are considered very attractive, with lower EV/EBITDA ratios and more favourable price multiples.

This peer comparison highlights that Vasundhara Rasayans Ltd occupies a middle ground in valuation terms. Its P/E ratio is significantly lower than the expensive peers but higher than some very attractive stocks in the sector, such as TGV Sraac, which trades at a P/E of 7.01 and an EV/EBITDA of 3.33.

Financial Performance and Return Metrics

Vasundhara Rasayans Ltd’s return profile over various time horizons reveals a mixed picture. The stock has delivered a remarkable 415.22% return over the past 10 years, significantly outperforming the Sensex’s 197.39% gain during the same period. However, more recent performance has been disappointing, with a 53.88% decline over the last year compared to a modest 1.65% drop in the Sensex. Year-to-date, the stock is down 30.34%, underperforming the benchmark’s 12.92% fall.

Shorter-term returns also reflect volatility, with a 1-month decline of 10.16% slightly worse than the Sensex’s 10.05% drop, while the 1-week return shows a modest 0.94% gain against the Sensex’s 2.40% loss. Over three years, the stock has declined 11.86%, contrasting with the Sensex’s 27.97% rise, though it has outperformed over five years with a 54.90% gain versus the Sensex’s 48.84%.

Profitability and Efficiency Indicators

Profitability metrics for Vasundhara Rasayans Ltd remain moderate. The return on capital employed (ROCE) is 10.75%, while return on equity (ROE) stands at 10.69%. These figures suggest the company generates reasonable returns on invested capital, though they are not exceptional within the sector. The dividend yield of 1.69% provides some income support but is unlikely to be a primary attraction for investors seeking growth or high yield.

The PEG ratio is reported as 0.00, which may indicate either a lack of earnings growth or data unavailability, signalling caution for growth-oriented investors.

Valuation Grade and Market Sentiment

MarketsMOJO has downgraded Vasundhara Rasayans Ltd’s Mojo Grade from Sell to Strong Sell as of 17 Dec 2025, reflecting deteriorating sentiment and valuation concerns. The company’s micro-cap status adds to the risk profile, with liquidity and volatility considerations likely influencing investor behaviour. The shift from an attractive to a fair valuation grade underscores the need for investors to reassess the stock’s risk-reward balance in the context of its sector and peer group.

Investor Takeaway and Outlook

Vasundhara Rasayans Ltd’s current valuation metrics suggest a stock that is fairly priced relative to its earnings and book value but lacks the compelling discount that might attract value investors. The downgrade in valuation grade and Mojo Score to Strong Sell signals caution, especially given the stock’s underperformance relative to the Sensex over the past year and year-to-date periods.

Investors should weigh the company’s moderate profitability and reasonable dividend yield against its recent price weakness and peer valuation context. While the stock’s long-term return track record is impressive, the recent negative momentum and valuation shift imply that a more cautious stance is warranted.

For those considering exposure to the Pharmaceuticals & Biotechnology sector, it is prudent to compare Vasundhara Rasayans Ltd with peers that offer either stronger growth prospects or more attractive valuation metrics. The sector’s wide valuation dispersion—from very attractive to very expensive—provides opportunities for selective investment based on individual risk tolerance and investment horizon.

Conclusion

In summary, Vasundhara Rasayans Ltd’s transition from an attractive to a fair valuation grade reflects changing market dynamics and investor sentiment. Its P/E of 9.91 and P/BV of 1.06 position it as a fairly valued micro-cap stock within a sector marked by significant valuation disparities. The downgrade to a Strong Sell Mojo Grade further emphasises the need for investors to exercise caution and consider alternative opportunities within the Pharmaceuticals & Biotechnology space.

Continuous monitoring of the company’s financial performance, sector developments, and peer valuations will be essential for making informed investment decisions going forward.

Limited Period Only. Get Started for only Rs. 16,999 - Get MojoOne for 2 Years + 1 Year Absolutely FREE! (72% Off) Get 72% Off →